If pathogenic or likely pathogenic alterations in BRCA1, BRCA2, ATM, PALB2, and CHEK2 are found, and/or there is a strong family history of cancer, then patients should be referred for genetic counselling and confirmatory germline testing. This evidence concerns the gene BRCA2 and cancer.